In vivo, TRAIL-encapsulated nanogel significantly reduced TNF-α and IL-6 levels, blood bacterial load, and pulmonary leukocytes accumulation; thus, it protected mice against K. pneumoniae-induced sepsis and LPS-induced lung and kidney injury and prolonged their survival rates. Here, IL6 is linked to Sepsis.